Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 455.00
-6.00 (-1.30%)
At close: Mar 26, 2026
Bora Pharmaceuticals Revenue
In the year 2025, Bora Pharmaceuticals had annual revenue of 19.01B TWD with 9.11% growth. Bora Pharmaceuticals had revenue of 4.86B in the quarter ending December 31, 2025, a decrease of -5.15%.
Revenue
19.01B
Revenue Growth
+9.11%
P/S Ratio
3.04
Revenue / Employee
n/a
Employees
n/a
Market Cap
57.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 19.01B | 1.59B | 9.11% |
| Dec 31, 2024 | 17.43B | 3.23B | 22.72% |
| Dec 31, 2023 | 14.20B | 3.71B | 35.31% |
| Dec 31, 2022 | 10.49B | 5.59B | 114.18% |
| Dec 31, 2021 | 4.90B | 3.10B | 172.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| PharmaEssentia | 15.63B |
| Grape King Bio | 10.25B |
| YungShin Global Holding | 8.37B |
| Standard Chemical & Pharmaceutical | 7.02B |
| TTY Biopharm Company | 6.45B |
| Synmosa Biopharma | 6.11B |
| ScinoPharm Taiwan | 3.16B |